172 related articles for article (PubMed ID: 29743796)
1. Increased Incidence of Post-transplant Lymphoproliferative Disorder in Autoimmune Liver Disease: An Irish National Experience.
Abu-Shanab A; Ged Y; Ullah N; Houlihan D; McCormick A
J Clin Exp Hepatol; 2018 Mar; 8(1):42-49. PubMed ID: 29743796
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus status and immunosuppression use in paediatric autoimmune liver disease.
Nayagam JS; Heneghan MA; Samyn M; Joshi D
Aliment Pharmacol Ther; 2022 Feb; 55(4):455-463. PubMed ID: 34796537
[TBL] [Abstract][Full Text] [Related]
3. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
4. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders.
Afify ZAM; Taj MM; Orjuela-Grimm M; Srivatsa K; Miller TP; Edington HJ; Dalal M; Robles J; Ford JB; Ehrhardt MJ; Ureda TJ; Rubinstein JD; McCormack S; Rivers JM; Chisholm KM; Kavanaugh MK; Bukowinski AJ; Friehling ED; Ford MC; Reddy SN; Marks LJ; Smith CM; Mason CC
Cancer; 2023 Mar; 129(5):780-789. PubMed ID: 36571557
[TBL] [Abstract][Full Text] [Related]
5. Post-transplant lymphoproliferative disease in liver transplantation.
Dhillon MS; Rai JK; Gunson BK; Olliff S; Olliff J
Br J Radiol; 2007 May; 80(953):337-46. PubMed ID: 17392399
[TBL] [Abstract][Full Text] [Related]
6. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.
McDiarmid SV; Jordan S; Kim GS; Toyoda M; Goss JA; Vargas JH; Martín MG; Bahar R; Maxfield AL; Ament ME; Busuttil RW
Transplantation; 1998 Dec; 66(12):1604-11. PubMed ID: 9884246
[TBL] [Abstract][Full Text] [Related]
7. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated risk factors for post-transplant lymphoproliferative disease in pediatric liver transplant recipients.
Quintero Bernabeu J; Juamperez J; Mercadal-Hally M; Larrarte King M; Gallego Melcon S; Gros Subias L; Sábado Álvarez C; Soler-Palacin P; Melendo Pérez S; Esperalba J; Navarro Jiménez A; Garrido Pontnou M; Camacho Soriano J; Hidalgo Llompart E; Bilbao Aguirre I; Charco Torra R
Pediatr Transplant; 2022 Sep; 26(6):e14292. PubMed ID: 35466492
[TBL] [Abstract][Full Text] [Related]
9. Acute tonsillitis as the first manifestation of post-transplant lymphoproliferative disorder.
Nouwen J; Smets F; Rombaux P; Hamoir M; Sokal EM
Ann Otol Rhinol Laryngol; 2002 Feb; 111(2):165-8. PubMed ID: 11860070
[TBL] [Abstract][Full Text] [Related]
10. Single-institution Retrospective Analysis of Prognostic Factors Influencing Very Late-onset Post-transplant Lymphoproliferative Disorder.
Bishnoi R; Minish J; Franke AJ; Skelton WP; Shah CP; Wang Y; Dang NH
Cureus; 2020 Feb; 12(2):e6912. PubMed ID: 32190467
[TBL] [Abstract][Full Text] [Related]
11. Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival.
Kremers WK; Devarbhavi HC; Wiesner RH; Krom RA; Macon WR; Habermann TM
Am J Transplant; 2006 May; 6(5 Pt 1):1017-24. PubMed ID: 16611339
[TBL] [Abstract][Full Text] [Related]
12. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
Filipec-Kanizaj T; Budimir J; Colić-Cvrlje V; Kardum-Skelin I; Sustercić D; Naumovski-Mihalić S; Mrzljak A; Kolonić SO; Sobocan N; Bradić T; Dolić ZM; Kocman B; Katicić M; Zidovec-Lepej S; Vince A
Acta Med Croatica; 2011 Sep; 65 Suppl 1():37-43. PubMed ID: 23126028
[TBL] [Abstract][Full Text] [Related]
13. Early Onset Post-transplant Lymphoproliferative Disorder Presenting with Diarrhea Post-orthotopic Liver Transplant Treated Successfully with Single Rituximab Agent.
Patek B; Strahotin C
Cureus; 2019 Nov; 11(11):e6200. PubMed ID: 31890402
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO
Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome from a single-centre experience with >1000 liver transplantations.
Mumtaz K; Faisal N; Marquez M; Healey A; Lilly LB; Renner EL
Can J Gastroenterol Hepatol; 2015; 29(8):417-22. PubMed ID: 26076399
[TBL] [Abstract][Full Text] [Related]
16. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
Fellner MD; Durand KA; Solernou V; Bosaleh A; Balbarrey Z; García de Dávila MT; Rodríguez M; Irazu L; Alonio LV; Picconi MA
Rev Argent Microbiol; 2016; 48(2):110-8. PubMed ID: 27157146
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr viral load monitoring for diagnosing post-transplant lymphoproliferative disorder in pediatric liver transplant recipients.
Seo E; Kim J; Oh SH; Kim KM; Kim DY; Lee J
Pediatr Transplant; 2020 Jun; 24(4):e13666. PubMed ID: 32067332
[TBL] [Abstract][Full Text] [Related]
19. Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative Disorder.
Sen A; Enriquez J; Rao M; Glass M; Balachandran Y; Syed S; Twist CJ; Weinberg K; Boyd SD; Bernstein D; Trickey AW; Gratzinger D; Tan B; Lapasaran MG; Robien MA; Brown M; Armstrong B; Desai D; Mazariegos G; Chin C; Fishbein TM; Venick RS; Tekin A; Zimmermann H; Trappe RU; Anagnostopoulos I; Esquivel CO; Martinez OM; Krams SM
Front Immunol; 2022; 13():994552. PubMed ID: 36304469
[TBL] [Abstract][Full Text] [Related]
20. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Allen UD; Preiksaitis JK;
Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
